Identification of the HDL-ApoCIII to VLDL-ApoCIII ratio as a predictor of coronary artery disease in the general population: The Chin-Shan Community Cardiovascular Cohort (CCCC) study in Taiwan

Table 3 Correlation of VLDL- and HDL-associated ApoE and ApoCIII with CAD in various lipidemic groups

	NL			HTG^a			HC^b			HLP^c
	(n=40)	(n=15)		(n=59)	(n=11)		(n=36)	(n=29)		(n=65)	(n=35)
	–	+		–	+		–	+		–	+
			P value			P value			P value			P value
VLDL-ApoE	1.3±0.2	0.6±0.3	NS	1.60±0.2	2.1±0.4	NS	1.1±0.2	0.8±0.2	NS	1.1±0.1	2.0±0.2	0.002
HDL-ApoE	1.9±0.2	2.3±0.3	NS	2.7±0.2	4.4±0.4	0.001	3.1±0.2	2.8±0.2	NS	3.8±0.1	4.1±0.2	NS
VLDL-ApoCIII	6.4±0.7	4.7±1.0	NS	9.3±0.6	3.8±1.3	0.0004	14.0±0.7	5.9±0.8	0.0001	9.6±0.5	5.1±0.7	0.0001
HDL-ApoCIII	8.3±0.5	13.7±0.8	0.0001	7.5±0.4	12.1±1.0	0.0001	7.2±0.5	12.0±0.6	0.0001	12.7±0.4	11.4±0.5	NS
HDL-ApoCIII to VLDL-ApoCIII ratio	1.8±0.5	4.6±0.7	0.002	1.1±0.4	8.4±1.0	0.0001	0.6±0.5	3.6±0.6	0.0001	1.6±0.4	4.2±0.5	0.0001

Data are presented as mean ± standard error of the mean, and all units are mg/dL, except for the HDL-ApoCIII to VLDL-ApoCIII ratio.
VLDL = very low-density lipoprotein; HDL = high-density lipoprotein; Apo = apolipoprotein; CAD = coronary artery disease; NL = normolipidemic; HTG = hypertriglyceridemic; HC = hypercholesterolemic; HLP = hyperlipidemic; NS = nonsignificant.
^aTG > 150 mg/dL.
^bTC > 200 mg/dL.
^cHC + HTG.

ISSN: 1476-511X